174 related articles for article (PubMed ID: 34432293)
1. Personalized sedation goal for agitated delirium in patients with cancer: Balancing comfort and communication.
Hui D; De La Rosa A; Urbauer DL; Nguyen T; Bruera E
Cancer; 2021 Dec; 127(24):4694-4701. PubMed ID: 34432293
[TBL] [Abstract][Full Text] [Related]
2. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.
Hui D; Frisbee-Hume S; Wilson A; Dibaj SS; Nguyen T; De La Cruz M; Walker P; Zhukovsky DS; Delgado-Guay M; Vidal M; Epner D; Reddy A; Tanco K; Williams J; Hall S; Liu D; Hess K; Amin S; Breitbart W; Bruera E
JAMA; 2017 Sep; 318(11):1047-1056. PubMed ID: 28975307
[TBL] [Abstract][Full Text] [Related]
3. The minimal clinically important difference of the Richmond Agitation-Sedation Scale in patients with cancer with agitated delirium.
Hui D; Hess K; Dibaj SS; Arthur J; Dev R; Dalal S; Reddy S; Bruera E
Cancer; 2018 May; 124(10):2246-2252. PubMed ID: 29469951
[TBL] [Abstract][Full Text] [Related]
4. Prehospital Agitation and Sedation Trial (PhAST): A Randomized Control Trial of Intramuscular Haloperidol versus Intramuscular Midazolam for the Sedation of the Agitated or Violent Patient in the Prehospital Environment.
Isenberg DL; Jacobs D
Prehosp Disaster Med; 2015 Oct; 30(5):491-5. PubMed ID: 26323511
[TBL] [Abstract][Full Text] [Related]
5. Association among rescue neuroleptic use, agitation, and perceived comfort: secondary analysis of a randomized clinical trial on agitated delirium.
Tang M; Chen M; Bruera E; Hui D
Support Care Cancer; 2021 Dec; 29(12):7887-7894. PubMed ID: 34184130
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic strategies for terminal agitation in patients with cancer and delirium at an acute palliative care unit: a single-centre, double-blind, parallel-group, randomised trial.
Hui D; De La Rosa A; Wilson A; Nguyen T; Wu J; Delgado-Guay M; Azhar A; Arthur J; Epner D; Haider A; De La Cruz M; Heung Y; Tanco K; Dalal S; Reddy A; Williams J; Amin S; Armstrong TS; Breitbart W; Bruera E
Lancet Oncol; 2020 Jul; 21(7):989-998. PubMed ID: 32479786
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Pharmacological Treatments for Agitated Delirium in the Last Days of Life.
Kawashima N; Yokomichi N; Morita T; Yabuki R; Hisanaga T; Imai K; Hirose Y; Shimokawa M; Miwa S; Yamauchi T; Okamoto S; Satomi E
J Pain Symptom Manage; 2024 May; 67(5):441-452.e3. PubMed ID: 38355071
[TBL] [Abstract][Full Text] [Related]
8. Dexmedetomidine versus haloperidol for sedation of non-intubated patients with hyperactive delirium during the night in a high dependency unit: study protocol for an open-label, parallel-group, randomized controlled trial (DEX-HD trial).
Minami T; Watanabe H; Kato T; Ikeda K; Ueno K; Matsuyama A; Maeda J; Sakai Y; Harada H; Kuriyama A; Yamaji K; Kitajima N; Kamei J; Takatani Y; Sato Y; Yamashita Y; Mizota T; Ohtsuru S
BMC Anesthesiol; 2023 Jun; 23(1):193. PubMed ID: 37270483
[TBL] [Abstract][Full Text] [Related]
9. Effects of dexmedetomidine on delirium duration of non-intubated ICU patients (4D trial): study protocol for a randomized trial.
Louis C; Godet T; Chanques G; Bourguignon N; Morand D; Pereira B; Constantin JM;
Trials; 2018 Jun; 19(1):307. PubMed ID: 29866205
[TBL] [Abstract][Full Text] [Related]
10. Visualizing How to Use Antipsychotics for Agitated Delirium in the Last Days of Life.
Imai K; Morita T; Mori M; Kiuchi D; Yokomichi N; Miwa S; Okamoto S; Yamauchi T; Naito AS; Matsuda Y; Maeda I; Sugano K; Ikenaga M; Inoue S; Satomi E
J Pain Symptom Manage; 2023 Jun; 65(6):479-489. PubMed ID: 36682673
[TBL] [Abstract][Full Text] [Related]
11. Dexmedetomidine for the Treatment of Hyperactive Delirium Refractory to Haloperidol in Nonintubated ICU Patients: A Nonrandomized Controlled Trial.
Carrasco G; Baeza N; Cabré L; Portillo E; Gimeno G; Manzanedo D; Calizaya M
Crit Care Med; 2016 Jul; 44(7):1295-306. PubMed ID: 26925523
[TBL] [Abstract][Full Text] [Related]
12. Comparison and agreement between the Richmond Agitation-Sedation Scale and the Riker Sedation-Agitation Scale in evaluating patients' eligibility for delirium assessment in the ICU.
Khan BA; Guzman O; Campbell NL; Walroth T; Tricker JL; Hui SL; Perkins A; Zawahiri M; Buckley JD; Farber MO; Ely EW; Boustani MA
Chest; 2012 Jul; 142(1):48-54. PubMed ID: 22539644
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of antipsychotics for managing agitated delirium in patients with advanced cancer: a secondary analysis of a multicenter prospective observational study in Japan (Phase-R).
Kurisu K; Inada S; Maeda I; Nobata H; Ogawa A; Iwase S; Uchida M; Akechi T; Amano K; Nakajima N; Morita T; Sumitani M; Yoshiuchi K
Support Care Cancer; 2024 Feb; 32(3):147. PubMed ID: 38326487
[TBL] [Abstract][Full Text] [Related]
14. Propofol-Based Palliative Sedation to Treat Antipsychotic-Resistant Agitated Delirium.
Covarrubias-Gómez A; López Collada-Estrada M
J Pain Palliat Care Pharmacother; 2017; 31(3-4):190-194. PubMed ID: 28506099
[TBL] [Abstract][Full Text] [Related]
15. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial.
Pandharipande PP; Pun BT; Herr DL; Maze M; Girard TD; Miller RR; Shintani AK; Thompson JL; Jackson JC; Deppen SA; Stiles RA; Dittus RS; Bernard GR; Ely EW
JAMA; 2007 Dec; 298(22):2644-53. PubMed ID: 18073360
[TBL] [Abstract][Full Text] [Related]
16. 'Palliative sedation'? A retrospective cohort study on the use and labelling of continuously administered sedatives on a palliative care unit.
Schildmann E; Pörnbacher S; Kalies H; Bausewein C
Palliat Med; 2018 Jul; 32(7):1189-1197. PubMed ID: 29557260
[TBL] [Abstract][Full Text] [Related]
17. A National Multicenter Survey on Management of Pain, Agitation, and Delirium in Intensive Care Units in China.
Wang J; Peng ZY; Zhou WH; Hu B; Rao X; Li JG
Chin Med J (Engl); 2017 May; 130(10):1182-1188. PubMed ID: 28485318
[TBL] [Abstract][Full Text] [Related]
18. Dexmedetomidine for hyperactive delirium at the end of life: An open-label single arm pilot study with dose escalation in adult patients admitted to an inpatient palliative care unit.
Thomas B; Lo WA; Nangati Z; Barclay G
Palliat Med; 2021 Apr; 35(4):729-737. PubMed ID: 33593115
[TBL] [Abstract][Full Text] [Related]
19. Pain, Agitation, and Delirium Guidelines: Interprofessional Perspectives to Translate the Evidence.
Jablonski J; Gray J; Miano T; Redline G; Teufel H; Collins T; Pascual-Lopez J; Sylvia M; Martin ND
Dimens Crit Care Nurs; 2017; 36(3):164-173. PubMed ID: 28375992
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial.
Agar MR; Lawlor PG; Quinn S; Draper B; Caplan GA; Rowett D; Sanderson C; Hardy J; Le B; Eckermann S; McCaffrey N; Devilee L; Fazekas B; Hill M; Currow DC
JAMA Intern Med; 2017 Jan; 177(1):34-42. PubMed ID: 27918778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
